首页 | 官方网站   微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   15539篇
  免费   983篇
  国内免费   73篇
医药卫生   16595篇
  2023年   158篇
  2022年   121篇
  2021年   477篇
  2020年   322篇
  2019年   460篇
  2018年   506篇
  2017年   390篇
  2016年   404篇
  2015年   499篇
  2014年   643篇
  2013年   853篇
  2012年   1297篇
  2011年   1236篇
  2010年   732篇
  2009年   619篇
  2008年   1056篇
  2007年   1069篇
  2006年   1001篇
  2005年   920篇
  2004年   871篇
  2003年   829篇
  2002年   665篇
  2001年   116篇
  2000年   97篇
  1999年   125篇
  1998年   99篇
  1997年   83篇
  1996年   70篇
  1995年   68篇
  1994年   62篇
  1993年   64篇
  1992年   76篇
  1991年   64篇
  1990年   46篇
  1989年   38篇
  1988年   42篇
  1987年   48篇
  1986年   30篇
  1985年   33篇
  1984年   36篇
  1983年   24篇
  1982年   20篇
  1981年   17篇
  1980年   20篇
  1979年   22篇
  1978年   17篇
  1969年   13篇
  1968年   19篇
  1967年   12篇
  1966年   12篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Karyotypic analysis at time of diagnosis has an important value in determining initial response to treatment, remission duration and overall survival (OS) in acute myeloid leukemia (AML). Less is known about its value before allogeneic hematopoietic cell transplantation (allo‐HCT) in patients transplanted with active disease, either relapsed or primary refractory (Rel‐Ref) AML. We explored the impact of cytogenetic risk (stratification according to MRC‐UK) in 2089 patients with either Ref (n = 972) or Rel AML (n = 1117) transplanted during the period 2000‐2017. Overall, 154 patients had a favorable risk, 1283 had an intermediate risk and 652 had an adverse cytogenetic risk. Median follow‐up was 49 months. Compared to the favorable risk group, intermediate and adverse risk patients were associated with worse leukemia‐free survival and OS and also with a higher incidence of relapse. In a subgroup analysis of patients in the intermediate risk group harboring Fms‐like tyrosine kinase 3‐internal tandem duplication (FLT3‐ITD), this remained an important prognostic factor, being associated with worse outcomes. When analyzing patients according to the intensity of the conditioning regimen, no differences were observed for the main transplant outcomes. In conclusion, in patients diagnosed with AML and transplanted with active disease, karyotype remains an important prognostic factor, allowing splitting patients into different risk groups according to their cytogenetics. Similarly, FLT3‐ITD mutation also remains a negative prognostic factor in this population.  相似文献   
4.
5.
6.

Background

In the emergency department, rib fractures are a common finding in patients who sustain chest trauma. Rib fractures may be a sign of significant, underlying pathology, especially in the elderly patients where rib fractures are associated with significant morbidity and mortality. To date, no studies have evaluated the ability of ultrasound to detect rib fractures using cadaver models and subsequently use this model as a teaching tool.

Objectives

The purpose of this study was to determine if it is possible to generate rib fractures on cadaver models which could be accurately identified using ultrasound.

Methods

This was a cross-sectional study performed during one session at a cadaver lab. A single hemithorax from four adult cadavers were used as models. Single rib fractures on each of rib five through eight were created. Four subjects, blinded to the normal versus fractured ribs, were asked to identify the presence of a fracture on each rib.

Results

A total of 8 of 16 potential ribs had fractured induced by study staff. Mean accuracy was 55% for all subjects. The overall sensitivity and specificity for detecting rib fractures was 50% (CI: 31.89–68.11) and 59.38% (CI: 35.69–73.55) respectively. The overall PPV and NPV was 55.17% and 54.29% respectively.

Conclusions

In this pilot study, subjects were not able to detect induced rib fractures using ultrasound on cadaver models. The use of this model as a teaching tool in the detection of rib fractures requires further investigation.  相似文献   
7.
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号